Shandong Xinhua Pharmaceutical Company Limited (HKG: 0719)

Shandong Xinhua Pharmaceutical Company Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	9,843	11,897	17,740	6,846	5,447	4,336
Market Cap Growth	-10.11%	-32.94%	159.14%	25.67%	25.64%	27.25%
Enterprise Value	10,644	12,706	17,708	8,175	6,459	5,408
Last Close Price	5.89	5.46	7.41	4.12	3.01	3.14
PE Ratio	8.18	6.88	10.74	6.04	4.87	5.85
PS Ratio	0.44	1.33	2.09	0.85	0.76	0.69
PB Ratio	0.74	2.26	3.61	1.53	1.35	1.25
P/TBV Ratio	2.12	2.66	4.30	1.86	1.65	1.52
P/FCF Ratio	21.47	-	30.56	563.90	32.76	-
P/OCF Ratio	20.93	40.71	20.70	21.52	10.92	11.13
EV/Sales Ratio	1.15	1.42	2.09	1.02	0.91	0.86
EV/EBITDA Ratio	9.52	11.27	16.45	7.93	6.45	6.59
EV/EBIT Ratio	20.16	22.52	33.62	16.50	11.85	12.39
EV/FCF Ratio	56.85	-	30.51	673.39	38.85	-
Debt / Equity Ratio	0.33	0.28	0.32	0.45	0.49	0.49
Debt / EBITDA Ratio	1.64	1.32	1.45	1.95	1.95	2.08
Debt / FCF Ratio	9.80	-	2.70	166.46	11.75	-
Asset Turnover	1.00	0.98	0.96	0.91	0.89	0.91
Inventory Turnover	5.66	4.58	4.92	4.48	3.76	3.64
Quick Ratio	0.84	0.76	0.68	0.65	0.59	0.47
Current Ratio	1.34	1.33	1.09	1.10	1.13	0.98
Return on Equity (ROE)	9.42%	11.09%	10.65%	10.28%	10.68%	10.91%
Return on Assets (ROA)	3.56%	3.87%	3.73%	3.50%	4.24%	3.94%
Return on Capital (ROIC)	4.65%	5.39%	5.28%	4.88%	5.93%	5.49%
Earnings Yield	4.84%	4.60%	2.62%	6.25%	7.08%	7.74%
FCF Yield	1.82%	-0.55%	3.27%	0.18%	3.05%	-0.47%
Dividend Yield	0.91%	5.05%	3.05%	4.47%	5.92%	4.28%
Payout Ratio	49.97%	35.43%	39.66%	42.59%	39.05%	38.80%
Buyback Yield / Dilution	-0.91%	-3.20%	-6.92%	0.02%	-0.86%	0.14%
Total Shareholder Return	-0.00%	1.85%	-3.87%	4.48%	5.06%	4.41%

Source: S&P Capital IQ. Standard template. Financial Sources.